Ethical Issues Involved in Grateful Patient Fundraising - Reply

Megan E. Collins; Steven A. Rum; Jeremy Sugarman

doi:10.1001/jama.2018.18672

Ethical Issues Involved in Grateful Patient Fundraising - Reply

Megan E. Collins, Steven A. Rum, Jeremy Sugarman

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	408
Number of pages	1
Journal	JAMA - Journal of the American Medical Association
Volume	321
Issue number	4
DOIs	https://doi.org/10.1001/jama.2018.18672
State	Published - Jan 29 2019

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2018.18672

Cite this

@article{d94c00f5a0324238aee59b74ec314539,

title = "Ethical Issues Involved in Grateful Patient Fundraising - Reply",

author = "Collins, {Megan E.} and Rum, {Steven A.} and Jeremy Sugarman",

note = "Funding Information: Conflict of Interest Disclosures: Dr Psaty reported receiving grants from the National Heart, Lung, and Blood Institute; serving on the data safety and monitoring board for a clinical trial of a device funded by Zoll LifeCor and on the steering committee for the Yale Open Data Access Project, funded by Johnson & Johnson; and receiving travel support from Wake Forest University for a grand rounds presentation. No other disclosures were reported. Funding Information: Author Affiliation: Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor. Corresponding Author: Reshma Jagsi, MD, DPhil, Department of Radiation Oncology, University of Michigan, UHB2C490, SPC 5010, 1500 E Medical Center Dr, Ann Arbor, MI 48109-5010 (rjagsi@med.umich.edu). Conflict of Interest Disclosures: Dr Jagsi reported receiving grants from the Greenwall Foundation, the National Cancer Institute, the Komen Foundation, the Doris Duke Charitable Foundation, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium; receiving consulting fees from Amgen and Vizient; and having stock options in Equity Quotient. 1. Collins ME, Rum SA, Sugarman J. Navigating the ethical boundaries of grateful patient fundraising. JAMA. 2018;320(10):975-976. doi:10.1001/jama. 2018.11655 2. Walter JK, Griffith KA, Jagsi R. Oncologists{\textquoteright} experiences and attitudes about their role in philanthropy and soliciting donations from grateful patients. J Clin Oncol. 2015;33(32):3796-3801. doi:10.1200/JCO.2015.62.6804 3. Prokopetz JJ, Lehmann LS. Physicians as fundraisers: medical philanthropy and the doctor-patient relationship. PLoS Med. 2014;11(2):e1001600. doi:10. 1371/journal.pmed.1001600 4. American Medical Association. Delivering care: ethics. https://www.ama-assn.org/delivering-care/ama-code-medical-ethics. Accessed July 17, 2018.",

year = "2019",

month = jan,

day = "29",

doi = "10.1001/jama.2018.18672",

language = "English (US)",

volume = "321",

pages = "408",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "4",

}

TY - JOUR

T1 - Ethical Issues Involved in Grateful Patient Fundraising - Reply

AU - Collins, Megan E.

AU - Rum, Steven A.

AU - Sugarman, Jeremy

N1 - Funding Information: Conflict of Interest Disclosures: Dr Psaty reported receiving grants from the National Heart, Lung, and Blood Institute; serving on the data safety and monitoring board for a clinical trial of a device funded by Zoll LifeCor and on the steering committee for the Yale Open Data Access Project, funded by Johnson & Johnson; and receiving travel support from Wake Forest University for a grand rounds presentation. No other disclosures were reported. Funding Information: Author Affiliation: Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor. Corresponding Author: Reshma Jagsi, MD, DPhil, Department of Radiation Oncology, University of Michigan, UHB2C490, SPC 5010, 1500 E Medical Center Dr, Ann Arbor, MI 48109-5010 (rjagsi@med.umich.edu). Conflict of Interest Disclosures: Dr Jagsi reported receiving grants from the Greenwall Foundation, the National Cancer Institute, the Komen Foundation, the Doris Duke Charitable Foundation, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium; receiving consulting fees from Amgen and Vizient; and having stock options in Equity Quotient. 1. Collins ME, Rum SA, Sugarman J. Navigating the ethical boundaries of grateful patient fundraising. JAMA. 2018;320(10):975-976. doi:10.1001/jama. 2018.11655 2. Walter JK, Griffith KA, Jagsi R. Oncologists’ experiences and attitudes about their role in philanthropy and soliciting donations from grateful patients. J Clin Oncol. 2015;33(32):3796-3801. doi:10.1200/JCO.2015.62.6804 3. Prokopetz JJ, Lehmann LS. Physicians as fundraisers: medical philanthropy and the doctor-patient relationship. PLoS Med. 2014;11(2):e1001600. doi:10. 1371/journal.pmed.1001600 4. American Medical Association. Delivering care: ethics. https://www.ama-assn.org/delivering-care/ama-code-medical-ethics. Accessed July 17, 2018.

PY - 2019/1/29

Y1 - 2019/1/29

UR - http://www.scopus.com/inward/record.url?scp=85060638896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060638896&partnerID=8YFLogxK

U2 - 10.1001/jama.2018.18672

DO - 10.1001/jama.2018.18672

M3 - Letter

C2 - 30694313

AN - SCOPUS:85060638896

SN - 0098-7484

VL - 321

SP - 408

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 4

ER -

Ethical Issues Involved in Grateful Patient Fundraising - Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this